7/7/2016 | PP | Icagen raises $1.15 million via private placement of 8% convertibles
|
4/9/2010 | CVPF | Icagen files $25 million shelf for stock, preferreds, debt securities
|
9/9/2009 | SS | Icagen shareholder Xmark sells 213,600 shares, cuts stake to 8.1%
|
1/20/2009 | SS | Icagen shareholder pushes for sale, may take legal action
|
12/3/2008 | SS | Icagen adopts shareholder rights plan
|
9/26/2008 | SS | Xmark Opportunity buys 625,708 shares of Icagen
|
2/6/2008 | PP | New Issue: Icagen to exercise option to sell $10 million of shares to Pfizer
|
2/6/2008 | PP | Market Commentary: Icagen puts $10 million of stock to Pfizer; Bankers completes part one of sale; Pegasus, Strategic to place
|
8/14/2007 | PP | New Issue: Icagen arranges $15 million stock purchase agreement with Pfizer
|
1/30/2007 | PP | Market Commentary: Xtreme Coil prices C$54.6 million stock offering; Open Range Energy arranges C$10 million issue
|
1/29/2007 | PP | New Issue: Icagen secures $21.87 million from private placement of stock
|
1/29/2007 | PP | Market Commentary: Icagen prepares to settle $21.87 million stock sale; StockerYale pockets $2.3 million from PIPE
|
11/13/2006 | BT | Icagen says third-quarter revenue falls by 7%, net loss rises by 14%
|
9/12/2006 | BT | Icagen to continue Assert trial testing ICA-17043
|
8/10/2006 | BT | Icagen: second-quarter revenues up 52% at $2.6 million, net loss rises 31%
|
8/4/2006 | BT | Icagen to stop testing ICA-17043 in 50% of subjects in sickle-cell trial
|
6/21/2006 | BT | Enrollment in Icagen's phase 3 trial of ICA-17043 for sickle cell disease reaches 75%
|
5/31/2006 | BT | Icagen begins pediatric study of ICA-17043 for sickle cell disease
|
5/10/2006 | BTCV | Icagen files $75 million shelf
|
3/6/2006 | BT | Icagen's phase 3 trial of ICA-17043 for sickle cell anemia at enrollment midpoint
|
3/1/2006 | BT | Icagen 2005 loss rises 21% to $20.2 million on $8.8 million revenue
|
2/21/2006 | BT | Icagen extends credit line to cover planned capital spending
|
11/4/2005 | BT | Market Commentary: Introgen's stock lifts on Colgate-Palmolive alliance; Cytori, Olympus enter into joint venture
|
10/19/2005 | BT | Icagen: Extension study of sickle cell drug ICA-17043 shows long-term safety data
|